Expand mobile version menu

Real-Life Activities

Real-Life Math -- Solution

Here is what your press release might look like:

Today's date

Jergen Biotech
123 Biotech Lane
Any town, Any state 12345

CONTACT PERSON: Connie Pressperson, 555-1234

REF: Jergen Biotech to acquire BioSolutions

Jergen Biotech announced today that they have signed a merger agreement to acquire BioSolutions. BioSolutions is a manufacturer of instruments for invasive surgeries.

Jergen Biotech will acquire BioSolutions for half a million shares of common stock. The stock is valued at $65 million.

"The merger of our two companies will present a large, beneficial presence," says Charles Smith. He is CEO and president of Jergen Biotech.

BioSolutions' president Thomas Brown will join the Jergen Biotech management team immediately following the merger. "As we merge with Jergen, we will be in a position to increase our presence in the current market," says Brown.

The merger is subject to regulatory approval. Upon approval, the merger will be completed within 90 days.

For more information, please contact Connie Pressperson at 555-1234.